Related Experiment Video
Updated: Aug 12, 2026

08:46
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
Managing passively acquired autoimmune neonatal neutropenia: a case study
Y L Fung1, L A Pitcher, K Taylor
1The Innovation Laboratory, Australian Red Cross Blood Service, Brisbane, Australia. lfung@arcbs.redcross.org.au
Transfusion Medicine (Oxford, England)
|April 30, 2005
Summary
Autoimmune neutropenia (AIN) in pregnant women can lead to neutropenic neonates. Monitoring maternal autoantibodies and using granulocyte colony-stimulating factor (G-CSF) in the second pregnancy improved neonatal outcomes.
Area of Science:
- Immunology
- Neonatology
- Maternal-Fetal Medicine
Background:
- Autoimmune neutropenia (AIN) in pregnancy poses risks of neonatal neutropenia and sepsis.
- Neutrophil-specific autoantibodies can cross the placenta, affecting fetal neutrophil counts.
Observation:
- A woman with AIN experienced a neutropenic neonate in her first pregnancy with no intervention.
- In her second pregnancy, maternal autoantibody levels were monitored, and granulocyte colony-stimulating factor (G-CSF) was administered in the third trimester.
Findings:
- The second infant was born with normal neutrophil counts and an excellent Apgar score.
- This suggests a potential benefit of monitoring and G-CSF treatment during pregnancy.
Implications:
- Serial monitoring of maternal autoantibodies and timely G-CSF intervention may improve outcomes for neonates of mothers with AIN.
- This case provides insights for managing similar high-risk pregnancies.
More Related Videos
Related Concept Videos
Active versus Passive Immunity
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
Active Immunity
Active immunity refers to the resistance one develops...
Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

